Osteoclast synthesis and secretion and activation of latent transforming growth factor beta.
The coupling of bone resorption and formation suggests that autocrine and paracrine factors are produced and released within the local bone environment. Since osteoblasts secrete latent transforming growth factor beta (TGF-beta), and osteoclasts can activate this latent complex, one candidate paracrine coupling factor is TGF-beta. To examine whether TGF-beta is also a potential osteoclast-derived autocrine and paracrine factor, highly purified avian osteoclasts were examined for synthesis of TGF-beta and the mechanism by which osteoclasts activate the latent TGF-beta complex was investigated. TGF-beta protein production was measured within 4 h of culture in osteoclast-conditioned media using growth factor inhibition of CCL-64 cells and verified by blocking effects with anti-TGF-beta antibodies. Synthesis of TGF-beta was confirmed by northern blotting and metabolic labeling. Northern blots of total RNA revealed that osteoclasts expressed the mRNA for TGF-beta 2, beta 3, and beta 4. Biosynthetic studies suggest that TGF-beta 2 was the principle form secreted in culture. Nearly all the TGF-beta that was secreted had been activated by the osteoclasts. When presented with exogenous latent TGF-beta, osteoclasts activated latent TGF-beta from a variety of sources. Furthermore, osteoclast-conditioned media retained the ability to activate latent TGF-beta during cell-free incubations at 37 degrees C. Osteoclast-mediated activation was inhibited by proteinase inhibitors, weak base treatment of the cells, or disruption of the cytoskeletal network. These data suggest that osteoclasts may secrete proteinases into the extracellular milieu to activate latent TGF-beta and that TGF-beta may be an autocrine factor involved in regulating osteoclast activity.
Mayo Clinic and Foundation, Rochester, Minnesota.
M J
MJ
Oursler
D000818:Animals; D001862:Bone Resorption / Q000503:physiopathology; D002478:Cells, Cultured; D002645:Chickens; D010010:Osteoclasts / Q000187:drug effects / Q000378:metabolism*; D010012:Osteogenesis / Q000502:physiology; D011480:Protease Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism
D011480:Protease Inhibitors; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta